Hitchcock
Antony Hitchcock, Crewe GB
Patent application number | Description | Published |
---|---|---|
20130084337 | PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME - The invention relates to compositions of purified filamentous bacteriophage, as well as methods that allow reproducible purification of high concentrations of filamentous bacteriophage. | 04-04-2013 |
Antony G. Hitchcock, Crewe GB
Patent application number | Description | Published |
---|---|---|
20100233151 | COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES - A drug product comprising a combination of highly purified collagenase I and collagenase II from | 09-16-2010 |
20100330065 | COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES - A drug product comprising a combination of highly purified collagenase I and collagenase II from | 12-30-2010 |
20110158972 | COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES - A drug product comprising a combination of highly purified collagenase I and collagenase II from | 06-30-2011 |
20110189153 | Compositions and Methods for Treating Collagen-Mediated Diseases - A drug product comprising a combination of highly purified collagenase I and collagenase II from | 08-04-2011 |
20110189163 | Compositions and Methods for Treating Collagen-Mediated Diseases - A drug product comprising a combination of highly purified collagenase I and collagenase II from | 08-04-2011 |
20110243908 | Compositions and Methods for Treating Collagen-Mediated Diseases - A drug product comprising a combination of highly purified collagenase I and collagenase II from | 10-06-2011 |
20110243909 | Compositions and Methods for Treating Collagen-Mediated Diseases - A drug product comprising a combination of highly purified collagenase I and collagenase II from | 10-06-2011 |
20110243919 | Compositions and Methods for Treating Collagen-Mediated Diseases - A drug product comprising a combination of highly purified collagenase I and collagenase II from | 10-06-2011 |
20110243920 | COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES - A drug product comprising a combination of highly purified collagenase I and collagenase II from | 10-06-2011 |
20140004094 | COMPOSITIONS AND METHODS FOR TREATING COLLAGEN-MEDIATED DISEASES | 01-02-2014 |
Ian Hitchcock, Reading GB
Patent application number | Description | Published |
---|---|---|
20100126711 | DOWNHOLE MODULATOR APPARATUS - A modulator is disclosed for creating a pressure pulse in a fluid-filled well. The modulator comprises a tool body on which a plurality of extendable arms are mounted. The arms may be retracted into a stowed position substantially adjacent the tool body, or may be extended to meet the wall of the borehole. The arms are preferably resilient bowsprings that may be flexed outwards from the tool by means of an actuator pushing on at least one end of the springs. A flexible valve sleeve or bag is suspended between the arms and cooperates with a valve mounted adjacent the sleeve on the tool body. The valve sleeve creates a fluid-flow path through the valve, and in operation, the valve closes one end of the valve sleeve to create the pressure pulse. Sealing of the valve sleeve against the wall of the well is a result of the fluid pressure inflating the sleeve against the well wall. As a result, sealing takes place over an extended area of the bag and is dynamically responsive to changes in fluid flow or pressure. | 05-27-2010 |
Marion Hitchcock, Berlin DE
Patent application number | Description | Published |
---|---|---|
20090082328 | Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity - This invention relates to novel substituted phenylamino-benzene compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients. | 03-26-2009 |
20110039819 | SUBSTITUTED PHENOXYBENZAMIDES - The present invention relates to substituted phenoxybenzamide compounds of general formula (I): in which R | 02-17-2011 |
20110071125 | SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY - This invention relates to novel substituted phenylamino-benzene compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients. | 03-24-2011 |
20110218219 | SUBSTITUTED SULPHONAMIDO PHENOXYBENZAMIDES - The present invention relates to substituted sulphonamido phenoxybenzamide compounds of general formula (I): | 09-08-2011 |
20110237592 | SUBSTITUTED AMIDO PHENOXYBENZAMIDES - The present invention relates to substituted amido phenoxybenzamide compounds of general formula (I): | 09-29-2011 |
20120107307 | DIHYDROPYRIDIN SULFONAMIDES AND DIHYDROPYRIDIN SULFAMIDES AS MEK INHIBITORS - This invention concerns N-(ortho phenylamino dihydropyridyl)sulfonamides and N-(ortho phenylamino dihydropyridyl), N′-alkyl sulfamides which are inhibitors of MEK and are useful in the treatment of cancer and other hyperproliferative diseases. | 05-03-2012 |
20120263714 | SUBSTITUTED HALOPHENOXYBENZAMIDE DERIVATIVES - The present invention relates to substituted halophenoxybenzamide derivative compounds of general formula (I) in which R | 10-18-2012 |
20120269803 | SUBSTITUTED BENZOSULPHONAMIDES - The present invention relates to substituted benzosulphonamide compounds of general formula (I): in which R1, R2, R3, R4, R5 and A are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients. | 10-25-2012 |
20120269804 | SUBSTITUTED BENZOSULPHONAMIDES - The present invention relates to substituted benzosulphonamide compounds of general formula (I): in which R1, R2, R3, R4, R5 and A are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients. | 10-25-2012 |
20130252922 | SUBSTITUTED PHENOXYPYRIDINES - The present invention relates to substituted phenoxypyridine compounds of general formula (I) in which R1, R2 and R3 are as defined in the claims, to methods of preparing said compounds, to intermediates for the preparation of said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients. | 09-26-2013 |
20130261120 | SUBSTITUTED N-(2-ARYLAMINO)ARYL SULFONAMIDE-CONTAINING COMBINATIONS - The present invention relates to: | 10-03-2013 |
20140249133 | SUBSTITUTED BENZYLINDAZOLES FOR USE AS BUB1 KINASE INHIBITORS IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES - Compounds of formula (I) which are inhibitors of Bub1 kinase, processes for their production and their use as pharmaceuticals. | 09-04-2014 |
20140296231 | AMINO-SUBSTITUTED IMIDAZOPYRIDAZINES - The present invention relates to amino-substituted imidazopyridazine compounds of general formula (I): in which A, R1, R3 and n are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients. | 10-02-2014 |
20140315934 | SUBSTITUTED BENZYLPYRAZOLES - Compounds of formula (I) and their use as pharmaceutical. | 10-23-2014 |
20150141372 | SUBSTITUTED CYCLOALKENOPYRAZOLES AS BUB1 INHIBITORS FOR THE TREATMENT OF CANCER - Compounds of formula (I), processes for their production and their use as Bub1 kinase inhibitors for the treatment of hyperproliferative diseases and/or disorders responsive to induction of cell death. | 05-21-2015 |
Paul Hitchcock, Illawong AU
Patent application number | Description | Published |
---|---|---|
20110114766 | APPARATUS AND METHOD FOR SIZE REDUCTION - A method for size reduction of a material comprising the steps of: feeding material through a feed assembly into a cyclone chamber, the cyclone chamber having an elongate cylindrical conduit having a frusto-conical section; adding at least one viscosity modifying agent into the cyclone chamber; and providing a cyclonic fluid stream within the cyclone chamber. The invention also includes an apparatus for carrying out size reduction of a material comprising: a cyclone chamber having an elongate cylindrical conduit having a frusto-conical section; a device for creating a cyclonic fluid stream within the cyclone chamber, such that the frusto-conical section of the cyclone chamber terminates in an opening forming the inlet to the device; an air inlet tube in fluid connection with the cyclone chamber at the opposite end of the frusto-conical section; and a feed assembly for feeding material into the cyclone chamber. | 05-19-2011 |
Robin Hitchcock, Bella Vista, New South Wales AU
Patent application number | Description | Published |
---|---|---|
20100071700 | FOREHEAD SUPPORTS FOR FACIAL MASKS - A face mask assembly (FMA) for supplying breathable gas to a wearer. The face mask assembly (FMA) includes a mask frame including a support, a facial cushion attached to the mask frame, and a forehead support. The forehead support includes a forehead cushion assembly and an adjustment knob operatively coupled to the forehead cushion assembly. The adjustment knob is threadably engaged with the forehead cushion assembly such that turning movement of the adjustment knob causes the mask frame to be moved between retracted and extended positions with respect to the forehead cushion assembly. | 03-25-2010 |
Robin G. Hitchcock, Carlingford AU
Patent application number | Description | Published |
---|---|---|
20090095298 | Nasal assembly - A nasal assembly for delivering breathable gas to a patient includes a frame having an integrally formed first connector portion. A nozzle assembly includes a gusset or base portion and a pair of nozzles. At least one inlet conduit is structured to deliver breathable gas into the frame and nozzle assembly for breathing by the patient. A pair of second connector portions are removably and rotatably connected to respective first connector portions of the frame and are in communication with respective inlet conduits, e.g., directly or via angle connectors. A headgear assembly is removably connected to the pair of second connector portions and/or the angle connectors so as to maintain the frame and the nozzle assembly in a desired adjusted position on the patient's face. | 04-16-2009 |
20130008447 | NASAL ASSEMBLY - A nasal assembly for delivering breathable gas to a patient includes a frame having an integrally formed first connector portion. A nozzle assembly includes a gusset or base portion and a pair of nozzles. At least one inlet conduit is structured to deliver breathable gas into the frame and nozzle assembly for breathing by the patient. A pair of second connector portions are removably and rotatably connected to respective first connector portions of the frame and are in communication with respective inlet conduits, e.g., directly or via angle connectors. A headgear assembly is removably connected to the pair of second connector portions and/or the angle connectors so as to maintain the frame and the nozzle assembly in a desired adjusted position on the patient's face. | 01-10-2013 |
Robin G. Hitchcock, Normanhurst AU
Patent application number | Description | Published |
---|---|---|
20110041855 | Nasal assembly - A nasal assembly for delivering breathable gas to a patient includes a frame having an integrally formed first connector portion. A nozzle assembly includes a gusset or base portion and a pair of nozzles. At least one inlet conduit is structured to deliver breathable gas into the frame and nozzle assembly for breathing by the patient. A pair of second connector portions are removably and rotatably connected to respective first connector portions of the frame and are in communication with respective inlet conduits, e.g., directly or via angle connectors. A headgear assembly is removably connected to the pair of second connector portions and/or the angle connectors so as to maintain the frame and the nozzle assembly in a desired adjusted position on the patient's face. | 02-24-2011 |
20110162655 | Nasal Assembly - A nasal assembly for delivering breathable gas to a patient includes a frame having an integrally formed first connector portion. A nozzle assembly includes a gusset or base portion and a pair of nozzles. At least one inlet conduit is structured to deliver breathable gas into the frame and nozzle assembly for breathing by the patient. A pair of second connector portions are removably and rotatably connected to respective first connector portions of the frame and are in communication with respective inlet conduits, e.g., directly or via angle connectors. A headgear assembly is removably connected to the pair of second connector portions and/or the angle connectors so as to maintain the frame and the nozzle assembly in a desired adjusted position on the patient's face. | 07-07-2011 |
William Hitchcock, Bath GB
Patent application number | Description | Published |
---|---|---|
20110248543 | ADJUSTABLE ARMREST - An armrest includes a stem and a sleeve defining a cavity. At least a portion of the stem is received in the cavity, with the stem being moveable relative to the sleeve. The sleeve includes opposite side walls defining in part the cavity, wherein at least one of the side walls includes a plurality of vertically spaced recesses. A carrier is moveably coupled to the stem. At least one lock member is carried by the carrier and is moveable relative to the carrier between a locked position and an unlocked position as the carrier is moved. The at least one lock member is received in at least one of the vertically spaced recesses when moved to the locked position. The at least one lock member is displaced from the vertically spaced recesses when moved to the unlocked position. A method of adjusting the armrest is also provided, as well as an adjustable arm support supported by the stem and methods for the use thereof. | 10-13-2011 |
William Laurence Hitchcock, Sydney AU
Patent application number | Description | Published |
---|---|---|
20150352306 | PATIENT INTERFACE AND METHOD FOR MAKING SAME - A patient interface for delivery of a supply of pressurised air or breathable gas to an entrance of a patient's airways comprising: a cushion member that includes a retaining structure and a seal-forming structure permanently connected to the retaining structure; a frame member attachable to the retaining structure; and a positioning and stabilising structure attachable to the frame member. | 12-10-2015 |